Gilman Hill Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.42M | Sell |
13,594
-810
| -6% | -$174K | 0.47% | 81 |
|
|
2026
Q1 | $3.13M | Buy |
14,404
+125
| +0.9% | +$27.7K | 0.47% | 82 |
|
|
2025
Q4 | $3.26M | Buy |
14,279
+431
| +3% | +$98.2K | 0.51% | 75 |
|
|
2025
Q3 | $3.21M | Buy |
13,848
+586
| +4% | +$119K | 0.5% | 77 |
|
|
2025
Q2 | $2.46M | Sell |
13,262
-663
| -5% | -$123K | 0.4% | 82 |
|
|
2025
Q1 | $2.92M | Sell |
13,925
-5
| -0% | -$972 | 0.51% | 72 |
|
|
2024
Q4 | $2.48M | Hold |
13,930
| – | – | 0.43% | 84 |
|
|
2024
Q3 | $2.75M | Sell |
13,930
-255
| -2% | -$47.6K | 0.46% | 74 |
|
|
2024
Q2 | $2.43M | Sell |
14,185
-1,664
| -10% | -$276K | 0.44% | 78 |
|
|
2024
Q1 | $2.89M | Sell |
15,849
-505
| -3% | -$87K | 0.52% | 74 |
|
|
2023
Q4 | $2.53M | Sell |
16,354
-110
| -0.7% | -$16K | 0.47% | 73 |
|
|
2023
Q3 | $2.45M | Sell |
16,464
-2
| -0% | -$294 | 0.48% | 74 |
|
|
2023
Q2 | $2.22M | Sell |
16,466
-430
| -3% | -$63.1K | 0.41% | 83 |
|
|
2023
Q1 | $2.69M | Sell |
16,896
-63,968
| -79% | -$9.78M | 0.55% | 67 |
|
|
2022
Q4 | $13.1M | Sell |
80,864
-483
| -0.6% | -$74.1K | 2.68% | 1 |
|
|
2022
Q3 | $10.9M | Buy |
81,347
+1,625
| +2% | +$233K | 2.55% | 1 |
|
|
2022
Q2 | $12.2M | Buy |
79,722
+16,044
| +25% | +$2.45M | 2.63% | 1 |
|
|
2022
Q1 | $10.3M | Sell |
63,678
-33,552
| -35% | -$4.87M | 2.35% | 3 |
|
|
2021
Q4 | $13.2M | Sell |
97,230
-1,689
| -2% | -$200K | 2.93% | 2 |
|
|
2021
Q3 | $10.7M | Buy |
98,919
+5,711
| +6% | +$653K | 2.73% | 1 |
|
|
2021
Q2 | $10.5M | Sell |
93,208
-904
| -1% | -$102K | 2.69% | 1 |
|
|
2021
Q1 | $10.2M | Buy |
94,112
+8,283
| +10% | +$886K | 2.82% | 1 |
|
|
2020
Q4 | $9.2M | Sell |
85,829
-2,031
| -2% | -$195K | 3.01% | 2 |
|
|
2020
Q3 | $7.7M | Buy |
87,860
+308
| +0.4% | +$29K | 2.98% | 3 |
|
|
2020
Q2 | $8.6M | Sell |
87,552
-3,150
| -3% | -$277K | 3.43% | 2 |
|
|
2020
Q1 | $6.91M | Sell |
90,702
-3,166
| -3% | -$270K | 3.35% | 2 |
|
|
2019
Q4 | $8.31M | Sell |
93,868
-242
| -0.3% | -$20.1K | 2.71% | 2 |
|
|
2019
Q3 | $7.13M | Sell |
94,110
-2,245
| -2% | -$154K | 2.37% | 4 |
|
|
2019
Q2 | $7.01M | Buy |
96,355
+83,596
| +655% | +$6.57M | 2.36% | 3 |
|
|
2019
Q1 | $1.03M | Buy |
12,759
+990
| +8% | +$81K | 0.36% | 69 |
|
|
2018
Q4 | $1.08M | Buy |
11,769
+124
| +1% | +$10.9K | 0.46% | 61 |
|
|
2018
Q3 | $1.1M | Buy |
11,645
+154
| +1% | +$14.6K | 0.43% | 62 |
|
|
2018
Q2 | $1.06M | Sell |
11,491
-875
| -7% | -$85.5K | 0.44% | 60 |
|
|
2018
Q1 | $1.17M | Sell |
12,366
-1,675
| -12% | -$184K | 0.51% | 55 |
|
|
2017
Q4 | $1.36M | Sell |
14,041
-275
| -2% | -$25.9K | 0.55% | 49 |
|
|
2017
Q3 | $1.27M | Buy |
14,316
+262
| +2% | +$19.9K | 0.52% | 48 |
|
|
2017
Q2 | $1.02M | Buy |
14,054
+288
| +2% | +$19.4K | 0.44% | 54 |
|
|
2017
Q1 | $897K | Sell |
13,766
-560
| -4% | -$35.2K | 0.39% | 60 |
|
|
2016
Q4 | $897K | Sell |
14,326
-1,848
| -11% | -$113K | 0.33% | 57 |
|
|
2016
Q3 | $1.02M | Buy |
16,174
+102
| +0.6% | +$6.6K | 0.39% | 53 |
|
|
2016
Q2 | $995K | Buy |
16,072
+145
| +0.9% | +$8.84K | 0.41% | 52 |
|
|
2016
Q1 | $910K | Sell |
15,927
-1,500
| -9% | -$83.6K | 0.42% | 53 |
|
|
2015
Q4 | $1.03M | Sell |
17,427
-500
| -3% | -$28.8K | 0.5% | 45 |
|
|
2015
Q3 | $975K | Buy |
17,927
+239
| +1% | +$15.6K | 0.51% | 51 |
|
|
2015
Q2 | $1.19M | Buy |
17,688
+600
| +4% | +$39.2K | 0.56% | 49 |
|
|
2015
Q1 | $1M | Sell |
17,088
-750
| -4% | -$45.3K | 0.47% | 54 |
|
|
2014
Q4 | $1.17M | Sell |
17,838
-500
| -3% | -$31.5K | 0.59% | 51 |
|
|
2014
Q3 | $1.06M | Sell |
18,338
-25
| -0.1% | -$1.39K | 0.58% | 46 |
|
|
2014
Q2 | $1.04M | Buy |
18,363
+6,980
| +61% | +$366K | 0.54% | 52 |
|
|
2014
Q1 | $585K | Buy |
11,383
+4,000
| +54% | +$202K | 0.35% | 65 |
|
|
2013
Q4 | $390K | Buy |
7,383
+60
| +0.8% | +$2.95K | 0.26% | 71 |
|
|
2013
Q3 | $328K | Sell |
7,323
-4,100
| -36% | -$182K | 0.24% | 72 |
|
|
2013
Q2 | $472K | Buy |
+11,423
| New | +$500K | 0.34% | 61 |
|
Other funds holding ABBV
Gilman Hill Asset Management's ABBV Position: Q2 2026 in Review
Gilman Hill Asset Management reduced its AbbVie (ABBV) stake by 5.6% in Q2 2026, selling an estimated $174K and leaving 13,594 shares worth $3.42M. The position accounts for 0.47% of the portfolio, ranked #81.
Gilman Hill Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.2M in Q4 2021. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Gilman Hill Asset Management held 13,594 shares of AbbVie worth $3.42M as of Q2 2026.
- Gilman Hill Asset Management sold 810 AbbVie shares in Q2 2026, an estimated $174K.
- AbbVie made up 0.47% of Gilman Hill Asset Management's portfolio in Q2 2026, its #81 holding.
- Gilman Hill Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Gilman Hill Asset Management's AbbVie position peaked at $13.2M in Q4 2021.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.